MarketPulse — Real-Time Financial News & Market Analysis

Adobe pays $150M settlement for deceptive subscription practices. Despite beating earnings, stock trades near 52-week lows amid broader market pressure.

Greenwich LifeSciences deploys commercially manufactured GP2 across all 40 FLAMINGO-01 trial sites following FDA approval, scaling production capacity significantly.

Mawson Infrastructure regains Nasdaq compliance, settles $19M lawsuits, establishes M&A committee to pursue AI infrastructure opportunities.

Snowline Gold joins VanEck Junior Gold Miners ETF, boosting investor visibility for its 7.94M ounce Valley deposit in Yukon.

BIO-Europe Spring 2026 in Lisbon expects 3,700+ attendees, 20,000+ meetings, and robust partnering activity as global biopharma industry seeks strategic deals and investment opportunities.

Novo Nordisk has repurchased 6.6 million B shares for DKK 1.78 billion, progressing through its DKK 15 billion share buyback program launched in February 2026.

Bavarian Nordic repurchased 40,086 shares at DKK 177.15 average price under its DKK 200 million buyback program, bringing total treasury holdings to 1.74M shares.

Bavarian Nordic initiates share buyback program worth DKK 200M through May 2026, purchasing 40,086 shares at average price of DKK 177.15 on first day.

Global access solutions leader ASSA ABLOY reports record 2025 results despite tariffs and geopolitical headwinds, completing 23 acquisitions and launching new sustainability program through 2030.

Microsoft's Azure cloud platform drives 39% AI revenue growth while enterprise software remains strong. Stock trades at 24x forward earnings with $625B backlog.

Dan Loeb's Third Point reduced Amazon stake by 23% in Q4 while opening major 4.7M-share Chipotle position, signaling shift from tech to consumer stocks.

Musk pressures index operators to fast-track SpaceX's $1.75 trillion IPO inclusion, creating temporary buying support but masking extreme 110x P/S and 580x P/E valuations.

Global quantum dots market projected to exceed $53.17B by 2035 with 17.77% CAGR, driven by display, lighting, and solar applications.

Oculis presents Phase 2 ACUITY trial results for Privosegtor at neuro-ophthalmology conference, showing vision improvements. Breakthrough therapy advances to registrational PIONEER program.

Oculis presents Phase 2 data for Privosegtor, an FDA Breakthrough-designated optic neuritis therapy showing improved visual acuity and reduced nerve damage, advancing toward Phase 3 registration trial.

Willis partners with embedded insurance leader Qover to expand GB Affinity ecosystem, enabling faster, scalable insurance program launches across financial and retail sectors.

U.S. stock futures gain ground Monday as Trump urges allies to secure Strait of Hormuz. Markets price 99.1% chance of unchanged Fed rates in March.

Pentagon estimates Iran conflict will last 4-6 weeks, costing $12 billion in first six days. Energy Secretary warns of economic disruption; Senator flags escalation risks.

e.l.f. Beauty and Jakks Pacific trade at deeply discounted valuations with catalysts for growth in skincare expansion and children's entertainment.

Nvidia posts $216B revenue with 65% growth amid AI boom, but stock trades at cheapest valuation since ChatGPT, as diversification into PCs, analytics, and edge computing proceeds.